Back to BAX Stock Lookup

Baxter Int'l (BAX) – Press Releases

Sep 15, 2014 09:00 AM FDA Approves Baxter’s RIXUBIS [Coagulation Factor IX (Recombinant)] for Treatment of Children with Hemophilia B
Sep 12, 2014 07:02 PM FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency
Sep 10, 2014 04:30 PM Baxter Announces Baxalta as the Name of New Global Biopharmaceutical Company
Aug 21, 2014 09:00 AM Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients
Aug 19, 2014 04:30 PM Baxter Announces Hemodialysis Dialyzer Expansion in Opelika, Alabama
Aug 18, 2014 04:15 PM Baxter to Present at Morgan Stanley Global Healthcare Conference
Aug 7, 2014 09:00 AM Baxter Opens Its First State-of-the-Art Biologics Facility in Asia, Announces Expansion Plans with New Processing Suite
Aug 4, 2014 09:00 AM FDA Approves Baxter’s FLEXBUMIN 5%, First and Only 5% Human Albumin Solution in a Flexible Container
Jul 31, 2014 01:55 PM FDA Advisory Committee Panel Provides Favorable Recommendation on Baxter’s HyQvia for Primary Immunodeficiency
Jul 30, 2014 08:02 AM Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer
Jul 22, 2014 09:00 AM Baxter Declares Quarterly Dividend
Jul 17, 2014 07:00 AM Baxter Exceeds Expectations in Second Quarter with Strong Growth across Global Franchises
Jul 10, 2014 09:00 AM Baxter Appoints John Orloff, M.D., Vice President of BioScience R&D
Jul 9, 2014 09:00 AM Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment
Jul 7, 2014 09:00 AM Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-off and Baxter International Inc.
Jun 26, 2014 04:15 PM Baxter International Second Quarter 2014 Financial Results Conference Call
Jun 25, 2014 09:00 AM Baxter’s Fifteenth Sustainability Report Highlights Commitment to Innovative Programs and Sustainable Design

Back to BAX Stock Lookup